Q4 2018

A UnitedHealth Group Inc. (NYSE: UNH) divulgou seu resultado trimestral na terça-feira, 15 de janeiro. O conglomerado de saúde informou US $ 3,28 EPS para o trimestre, superando a estimativa de consenso da Thomson Reuters, que era de US $ 3,21, por US $ 0,07. O conglomerado de saúde reportou receita de US $ 58,42 bilhões durante o trimestre, ao passo que a estimativa de consenso era de US $ 58,01 bilhões. O UnitedHealth Group teve uma margem líquida de 5,71% e um retorno sobre o patrimônio de 23,62%. A receita da empresa no trimestre cresceu 12,2% em relação ao mesmo trimestre do ano passado. Durante o mesmo período do ano passado, a empresa reportou lucro de US $ 2,59 EPS.
NYSE:UNH - Stock Price, News, & Analysis for UnitedHealth Group

David Wichmann -- Chief Executive Officer

Good morning, everyone, and thank you for joining us today. At our Investor Conference just a few weeks ago, we provided an extensive and positive review of our business and expectations for 2019 and beyond. Our outlook today remains consistent with that view. We are strongly confident in the fundamentals of our business as we enter 2019; in our ability to invest, innovate and grow; and in the breadth of opportunities across healthcare available to a company with the unique capabilities we have built over time to deliver ever more value to society and consistent results for our shareholders.

The results we reported this morning bear that out. Full-year revenues exceeded $226 billion, growing 12% or $25 billion over 2017. Fourth quarter and full-year 2018 adjusted earnings per share were stronger than our investor conference outlook, with full-year adjusted earnings per share growing 28% to $12.88 per share.

UnitedHealth Group (UNH) Q4 2018 Earnings Conference Call Transcript -- The Motley Fool